Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee Magal

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pathogens (Basel, Switzerland)|October 29, 2025
Efficacy and Safety of Voriconazole for Difficult-to-Treat Distal Lateral Subungual Onychomycosis (DLSO)Aditya K Gupta, Mesbah Talukder, Elizabeth A Cooper, et al.
Dermatology Practical & Conceptual|May 26, 2026
Efficacy of Topical Steroidal Treatment and Hand-Care Modification in Chronic Paronychia: A Retrospective StudyEran Galili, Avner Shemer, Lee Magal, et al.
Life (Basel, Switzerland)|August 28, 2025
Onychomycosis in Diabetics: A Common Infection with Potentially Serious ComplicationsAditya K Gupta, Amanda Liddy, Lee Magal, et al.
Cutis|November 3, 2025
Epidemiologic and Clinical Evaluation of the Bidirectional Link Between Molluscum Contagiosum and Atopic Dermatitis in ChildrenAnna Lyakhovitsky, Avner Shemer, Eran Galili, et al.
Skinmed|March 18, 2024
Effect of the Intralesional Forms of Methylprednisolone Acetate and Methotrexate on Psoriatic NailsRiad Kassem, Aditya K Gupta, Mary A Bamimore, et al.
Experimental Dermatology|November 17, 2021
Vorinostat, a histone deacetylase inhibitor, as a potential novel treatment for psoriasisLiat Samuelov, Ron Bochner, Lee Magal, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 4, 2025
Trichophyton indotineae: Epidemiology, antifungal resistance and antifungal stewardship strategiesAditya K Gupta, Susmita, Hien C Nguyen, et al.
The Journal of Investigative Dermatology|March 29, 2014
A mutation in TP63 causing a mild ectodermal dysplasia phenotypeTomer Goldsmith, Ori Eytan, Lee Magal, et al.
European Journal of Haematology|July 7, 2019
A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chainTamar Tadmor, Andrei Braester, Dally Najib, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pathogens (Basel, Switzerland)|October 29, 2025
Efficacy and Safety of Voriconazole for Difficult-to-Treat Distal Lateral Subungual Onychomycosis (DLSO)Aditya K Gupta, Mesbah Talukder, Elizabeth A Cooper, et al.
Dermatology Practical & Conceptual|May 26, 2026
Efficacy of Topical Steroidal Treatment and Hand-Care Modification in Chronic Paronychia: A Retrospective StudyEran Galili, Avner Shemer, Lee Magal, et al.
Life (Basel, Switzerland)|August 28, 2025
Onychomycosis in Diabetics: A Common Infection with Potentially Serious ComplicationsAditya K Gupta, Amanda Liddy, Lee Magal, et al.
Cutis|November 3, 2025
Epidemiologic and Clinical Evaluation of the Bidirectional Link Between Molluscum Contagiosum and Atopic Dermatitis in ChildrenAnna Lyakhovitsky, Avner Shemer, Eran Galili, et al.
Skinmed|March 18, 2024
Effect of the Intralesional Forms of Methylprednisolone Acetate and Methotrexate on Psoriatic NailsRiad Kassem, Aditya K Gupta, Mary A Bamimore, et al.
Experimental Dermatology|November 17, 2021
Vorinostat, a histone deacetylase inhibitor, as a potential novel treatment for psoriasisLiat Samuelov, Ron Bochner, Lee Magal, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 4, 2025
Trichophyton indotineae: Epidemiology, antifungal resistance and antifungal stewardship strategiesAditya K Gupta, Susmita, Hien C Nguyen, et al.
The Journal of Investigative Dermatology|March 29, 2014
A mutation in TP63 causing a mild ectodermal dysplasia phenotypeTomer Goldsmith, Ori Eytan, Lee Magal, et al.
European Journal of Haematology|July 7, 2019
A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chainTamar Tadmor, Andrei Braester, Dally Najib, et al.
Pageof 1